Publications

Rhinehart DP, Lai J, Sanin DE, Vakkala V, Mendes A, Bailey C, Antonarakis ES, Paller CJ, Wu X, Lotan TL, Karchin R, Sena LA. Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancer. NPJ Precis Oncol. 2024 Dec 2;8(1):275. doi: 10.1038/s41698-024-00773-w. PMID: 39623053.